483
Allergan Sales, LLCFDA 483 - Allergan Sales, LLC - November 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Allergan Sales, LLC (BLI) in Irvine, CA, was cited for significant deficiencies in its drug substance manufacturing processes, particularly concerning contamination control and environmental monitoring. The inspection revealed inadequate process design, insufficient microbial control strategies, and flawed risk assessments, indicating a lack of assurance in maintaining drug substance quality and preventing contamination.
Open in Dashboard
ID · 22954531-e534-441b-863f-bbedcbf15b17